A Trial to Evaluate the Efficacy and Safety of RSVpreF in Infants Born to Women Vaccinated During Pregnancy.
A PHASE 3, RANDOMIZED, DOUBLE-BLINDED, PLACEBO-CONTROLLED TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF A RESPIRATORY SYNCYTIAL VIRUS (RSV) PREFUSION F SUBUNIT VACCINE IN INFANTS BORN TO WOMEN VACCINATED DURING PREGNANCY
2 other identifiers
interventional
14,727
18 countries
464
Brief Summary
This randomized, double-blinded, placebo-controlled Phase 3 study is designed to evaluate the efficacy and safety of maternal immunization with RSVpreF against medically attended lower respiratory tract illness (MA-LRTI) in infants.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_3
Started Jun 2020
Typical duration for phase_3
464 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 3, 2020
CompletedFirst Posted
Study publicly available on registry
June 9, 2020
CompletedStudy Start
First participant enrolled
June 17, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 27, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
October 27, 2023
CompletedResults Posted
Study results publicly available
February 11, 2025
CompletedFebruary 11, 2025
January 1, 2025
3.4 years
June 3, 2020
October 11, 2024
January 17, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (23)
Percentage of Infant Participants With Medically Attended Lower Respiratory Tract Illness (MA-LRTI) Cases Due to RSV Occurring Within 90 Days After Birth (Efficacy)
Results are presented as confirmed by endpoint adjudication committee. MA-LRTI case: infant with an MA-RTI visit with age related fast breathing (respiratory rate \[RR\] more than or equal to \[\>=\] 60 breaths per minute \[bpm\] for less than \[\<\] 2 months of age \[\<60 days of age\], \>=50 bpm for \>=2 months to \<12 months of age, or \>=40 bpm for \>=12 months to 24 months of age) or oxygen saturation (SpO2) \<95 percent (%) or chest wall indrawing and RSV positive test results by reverse transcription-polymerase chain reaction (RT-PCR) testing of midturbinate nasal swab samples.
Within 90 days after birth
Percentage of Infant Participants With MA-LRTI Cases Due to RSV Occurring Within 120 Days After Birth (Efficacy)
Results are presented as confirmed by endpoint adjudication committee. MA-LRTI case: Infant with an MA-RTI visit with age related fast breathing (RR \>=60 bpm for \<2 months of age \[\<60 days of age\], \>=50 bpm for \>=2 months to \<12 months of age, or \>=40 bpm for \>=12 months to 24 months of age) or SpO2 \<95% or chest wall indrawing and RSV positive test results by RT-PCR testing of midturbinate nasal swab samples.
Within 120 days after birth
Percentage of Infant Participants With MA-LRTI Cases Due to RSV Occurring Within 150 Days After Birth (Efficacy)
Results are presented as confirmed by endpoint adjudication committee. MA-LRTI case: Infant with an MA-RTI visit with age related fast breathing (RR \>=60 bpm for \<2 months of age \[\<60 days of age\], \>=50 bpm for \>=2 months to \<12 months of age, or \>=40 bpm for \>=12 months to 24 months of age) or SpO2 \<95% or chest wall indrawing and RSV positive test results by RT-PCR testing of midturbinate nasal swab samples.
Within 150 days after birth
Percentage of Infant Participants With MA-LRTI Cases Due to RSV Occurring Within 180 Days After Birth (Efficacy)
Results are presented as confirmed by endpoint adjudication committee. MA-LRTI case: Infant with an MA-RTI visit with age related fast breathing (RR \>=60 bpm for \<2 months of age \[\<60 days of age\], \>=50 bpm for \>=2 months to \<12 months of age, or \>=40 bpm for \>=12 months to 24 months of age) or SpO2 \<95% or chest wall indrawing and RSV positive test results by RT-PCR testing of midturbinate nasal swab samples.
Within 180 days after birth
Percentage of Infant Participants With Severe MA-LRTI Cases Due to RSV Occurring Within 90 Days After Birth (Efficacy)
Results are presented as confirmed by endpoint adjudication committee. Severe MA-LRTI cases were a subset of MA-LRTI cases, and all severe MA-LRTI cases included MA-LRTI cases. Severe MA-LRTI case was an RSV positively adjudicated event which met the following defined criteria: an infant with an MA-RTI visit and aged associated fast breathing (RR \>=70 bpm for \<2 months of age \[\<60 days of age\], \>=60 bpm for \>=2 months to \<12 months of age, or \>=50 bpm for \>=12 months to 24 months of age) or SpO2 \<93% or high-flow nasal cannula or mechanical ventilation (i.e., invasive or non-invasive) or intensive care unit (ICU) admission for more than (\>) 4 hours or failure to respond/unconscious.
Within 90 days after birth
Percentage of Infant Participants With Severe MA-LRTI Cases Due to RSV Occurring Within 120 Days After Birth (Efficacy)
Results are presented as confirmed by endpoint adjudication committee. Severe MA-LRTI cases were a subset of MA-LRTI cases, and all severe MA-LRTI cases were included MA-LRTI cases. Severe MA-LRTI case was an RSV positively adjudicated event which met the following defined criteria: an infant with an MA-RTI visit and aged associated fast breathing (RR \>=70 bpm for \<2 months of age \[\<60 days of age\], \>=60 bpm for \>=2 months to \<12 months of age, or \>=50 bpm for \>=12 months to 24 months of age) or SpO2 \<93% or high-flow nasal cannula or mechanical ventilation (i.e., invasive or non-invasive) or ICU admission for \>4 hours or failure to respond/unconscious.
Within 120 days after birth
Percentage of Infant Participants With Severe MA-LRTI Cases Due to RSV Occurring Within 150 Days After Birth (Efficacy)
Results are presented as confirmed by endpoint adjudication committee. Severe MA-LRTI cases were a subset of MA-LRTI cases, and all severe MA-LRTI cases were included MA-LRTI cases. Severe MA-LRTI case was an RSV positively adjudicated event which met the following defined criteria: an infant with an MA-RTI visit and aged associated fast breathing (RR \>=70 bpm for \<2 months of age \[\<60 days of age\], \>=60 bpm for \>=2 months to \<12 months of age, or \>=50 bpm for \>=12 months to 24 months of age) or SpO2 \<93% or high-flow nasal cannula or mechanical ventilation (i.e., invasive or non-invasive) or ICU admission for \>4 hours or failure to respond/unconscious.
Within 150 days after birth
Percentage of Infant Participants With Severe MA-LRTI Cases Due to RSV Occurring Within 180 Days After Birth (Efficacy)
Results are presented as confirmed by endpoint adjudication committee. Severe MA-LRTI cases were a subset of MA-LRTI cases, and all severe MA-LRTI cases were included MA-LRTI cases. Severe MA-LRTI case was an RSV positively adjudicated event which met the following defined criteria: an infant with an MA-RTI visit and aged associated fast breathing (RR \>=70 bpm for \<2 months of age \[\<60 days of age\], \>=60 bpm for \>=2 months to \<12 months of age, or \>=50 bpm for \>=12 months to 24 months of age) or SpO2 \<93% or high-flow nasal cannula or mechanical ventilation (i.e., invasive or non-invasive) or ICU admission for \>4 hours or failure to respond/unconscious.
Within 180 days after birth
Percentage of Infant Participants With Adverse Events of Special Interest (AESI) (Safety)
AESI are a subset of targeted medical events based on review of known pharmacology, toxicology findings, possible class effects, published literature, and signals arising from safety data assessments, and on population under study. AESIs were based on targeted medical events associated with pregnant maternal participants and their infants prior to/during delivery and at birth. For infant participants the following were considered as protocol defined AESIs: Preterm birth (born at \<37 weeks gestation); birth weight 1001-2500 grams; developmental delay; positive viral (polymerase chain reaction \[PCR\] or antigen-based) testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), when not reported during MA-RTI visit, were reported as SARS-CoV-2 test positive. Extremely preterm birth (\<28 weeks) and extremely low birth weight (=\<1000 grams \[g\]) were reported as serious AESIs.
From birth to 24 months of age
Percentage of Infant Participants With Neonatal Deaths (Safety)
Neonatal death was defined as the death of a live-born infant that occurred within a month after birth.
Within 1 Month after birth
Percentage of Infant Participants With Congenital Malformations/Anomalies (Safety)
Congenital malformations/ anomalies were defined as structural or functional anomalies that occurred during intrauterine life and could be identified prenatally, at birth or later in life.
At birth
Percentage of Infant Participants With Other Neonatal Events (Safety)
Other Neonatal problem included dysmaturity, neonatal illness, hospitalization, drug therapies, and neonatal death.
Within 1 Month after birth
Number of Infant Participants According to Appearance, Pulse, Grimace, Activity, and Respiration (APGAR) Score at 1 Minute After Birth (Safety)
APGAR was a fast evaluation technique used to evaluate a newborn baby's overall health. APGAR stands for (A) Appearance (skin coloration), (P) Pulse (heart rate), (G) Grimace (reflex response), (A) Activity (muscle tone) and (R) Respiration (breathing). Each component was given a score of 0, 1, or 2; after summing up scores for each component a total possible score was of 0 (worst condition) to 10 (best condition), where higher scores indicate better health. A score of 7 to 10 was good, 4 to \<7 was moderate, and \<4 was poor.
1 minute after birth
Number of Infant Participants According to APGAR Score at 5 Minutes After Birth (Safety)
APGAR was a fast evaluation technique used to evaluate a newborn baby's overall health. APGAR stands for (A) Appearance (skin coloration), (P) Pulse (heart rate), (G) Grimace (reflex response), (A) Activity (muscle tone) and (R) Respiration (breathing). Each component was given a score of 0, 1, or 2; after summing up scores for each component a total possible score was of 0 (worst condition) to 10 (best condition), where higher scores indicate better health. A score of 7 to 10 was good, 4 to \<7 was moderate, and \<4 was poor.
5 minutes after birth
Number of Infant Participants According to APGAR Score at 10 Minutes After Birth (Safety)
APGAR was a fast evaluation technique used to evaluate a newborn baby's overall health. APGAR stands for (A) Appearance (skin coloration), (P) Pulse (heart rate), (G) Grimace (reflex response), (A) Activity (muscle tone) and (R) Respiration (breathing). Each component was given a score of 0, 1, or 2; after summing up scores for each component a total possible score was of 0 (worst condition) to 10 (best condition), where higher scores indicate better health. A score of 7 to 10 was good, 4 to \<7 was moderate, and \<4 was poor.
10 minutes after birth
Percentage of Infant Participants With Adverse Events (AEs) From Birth to 1 Month of Age (Safety)
An AE was any untoward medical occurrence in a participant or clinical study participant, temporally associated with the use of study intervention, whether or not considered related to the study intervention.
From birth to 1 month of age
Percentage of Infant Participants With Serious Adverse Events (SAEs) and Newly Diagnosed Chronic Medical Conditions (NDCMCs) From Birth Through 6 Months of Age (Safety)
An AE was any untoward medical occurrence in a participant or clinical study participant, temporally associated with the use of study intervention, whether or not considered related to the study intervention. An SAE was any untoward medical occurrence that at any dose: resulted in death, was life threatening, required inpatient hospitalization or prolongation of existing hospitalization, resulted in persistent or significant disability/incapacity, resulted in congenital anomaly/birth defect or that was considered an important medical event. An NDCMC was defined as a disease or medical condition, not previously identified, that was expected to be persistent or otherwise long-lasting in its effects.
From birth to 6 months of age
Percentage of Infant Participants With SAEs and NDCMCs From Birth Through 12 Months of Age (Safety)
An AE was any untoward medical occurrence in a participant or clinical study participant, temporally associated with the use of study intervention, whether or not considered related to the study intervention. An SAE was any untoward medical occurrence that at any dose: resulted in death, was life threatening required inpatient hospitalization or prolongation of existing hospitalization, resulted in persistent or significant disability/incapacity, resulted in congenital anomaly/birth defect or that was considered an important medical event. An NDCMC was defined as a disease or medical condition, not previously identified, that was expected to be persistent or otherwise long-lasting in its effects.
From birth to 12 months of age
Percentage of Infant Participants With SAEs and NDCMCs From Birth Through 24 Months of Age (Safety)
An AE was any untoward medical occurrence in a participant or clinical study participant, temporally associated with the use of study intervention, whether or not considered related to the study intervention. An SAE was any untoward medical occurrence that at any dose: resulted in death, was life threatening required inpatient hospitalization or prolongation of existing hospitalization, resulted in persistent or significant disability/incapacity, resulted in congenital anomaly/birth defect or that was considered an important medical event. An NDCMC was defined as a disease or medical condition, not previously identified, that was expected to be persistent or otherwise long-lasting in its effects.
From birth to 24 months of age
Percentage of Maternal Participants With Prespecified Local Reactions Within 7 Days After Vaccination (Safety)
Local reactions included redness, swelling, and pain at injection site and were recorded in electronic diary (e-diary). Redness and swelling were measured and recorded in measuring device units. 1 measuring device unit= 0.5 centimetre (cm). Redness and swelling were graded as mild (\>2.0 to 5.0 cm), moderate (\>5.0 to 10.0 cm), severe (\>10.0 cm) and grade 4 (necrosis or exfoliative dermatitis for redness and necrosis for swelling). Pain at injection site was graded as mild (did not interfere with activity), moderate (interfered with activity), severe (prevented daily activity) and grade 4 (emergency room visit or hospitalization for the severe pain at the injection site). Grade 4 reactions were classified by the investigator or medically qualified person.
From Day 1 to Day 7 after vaccination
Percentage of Maternal Participants With Prespecified Systemic Events Within 7 Days After Vaccination (Safety)
Systemic events included: fever, fatigue, headache, nausea, muscle pain, joint pain, vomiting and diarrhea and were recorded by participants in an e-diary. Fever was defined as an oral temperature \>=38.0 degree Celsius \[C\]) and classified as mild (38.0 to 38.4), moderate (38.5 to 38.9), severe (39.0 to 40.0) and grade 4 (\>40.0 degree C). Headache, nausea, fatigue, muscle pain and joint pain were graded as mild (did not interfere with activity), moderate (some interference with activity), severe (prevented daily activity). Vomiting: mild (1-2 times in 24 hours \[H\]), moderate (\>2 times in 24 H), severe (required intravenous \[IV\] hydration). Diarrhea: mild (2-3 loose stools in 24 H), moderate (4-5 loose stools in 24 H), severe (\>=6 in 24 H). For all systemic events except fever, Grade 4= emergency room visit or hospitalization. Grade 4 events were classified by investigator or medically qualified person.
From Day 1 to Day 7 after vaccination
Percentage of Maternal Participants With AEs From the Time of Vaccination Through 1 Month After Vaccination (Safety)
An AE was any untoward medical occurrence in a participant or clinical study participant, temporally associated with the use of study intervention, whether or not considered related to the study intervention Only AEs collected by non-systematic assessment (i.e. excluding local reactions and systemic events) were included in this outcome measure.
From vaccination on Day 1 up to 1 month after vaccination
Percentage of Maternal Participants With SAEs Throughout the Study Period (Safety)
An AE was any untoward medical occurrence in a participant or clinical study participant, temporally associated with the use of study intervention, whether or not considered related to the study intervention. An SAE was any untoward medical occurrence that at any dose: resulted in death, was life threatening, required inpatient hospitalization or prolongation of existing hospitalization, resulted in persistent or significant disability/incapacity, resulted in congenital anomaly/birth defect or that was considered an important medical event.
From vaccination on Day 1 up to 6 months after delivery (maximum up to 10 months)
Secondary Outcomes (3)
Percentage of Infant Participants With Cases of Hospitalization Due to RSV Within 90, 120, 150, 180 and 360 Days After Birth (Efficacy)
Within 90, 120, 150, 180 and 360 days after birth
Percentage of Infant Participants With MA-LRTI Cases Due to Any Cause With Protocol Defined Criteria Occurring Within 90, 120, 150, 180 and 360 Days After Birth (Efficacy)
Within 90, 120, 150, 180 and 360 days after birth
Percentage of Infant Participants With MA-LRTI Cases Due to RSV Occurring Within 210, 240, 270 and 360 Days After Birth (Efficacy)
Within 210, 240, 270 and 360 days after birth
Study Arms (2)
RSVpreF vaccine
EXPERIMENTALRSVpreF
Placebo dose
PLACEBO COMPARATORPlacebo
Interventions
Eligibility Criteria
You may qualify if:
- Healthy women ≤49 years of age who are between 24 0/7 and 36 0/7 weeks of gestation on the day of planned vaccination, with an uncomplicated, singleton pregnancy, who are at no known increased risk for complications.
- Willing and able to comply with scheduled visits, treatment plan, laboratory tests, and other study procedures.
- Receiving prenatal standard of care based on country requirements.
- Had a fetal anomaly ultrasound examination performed at ≥18 weeks of pregnancy with no significant fetal abnormalities observed.
- Documented negative HIV antibody test, syphilis test, and hepatitis B virus (HBV) surface antigen test during this pregnancy and prior to randomization (Visit 1).
- Intention to deliver at a hospital or birthing facility where study procedures can be obtained.
- Expected to be available for the duration of the study and can be contacted by telephone during study participation.
- Participant is willing to give informed consent for her infant to participate in the study.
- Capable of giving signed informed consent which includes compliance with the requirements and restrictions listed in the informed consent document (ICD) and in this protocol OR If the maternal participant is illiterate, a thumbprinted informed consent must be obtained, which must be signed and dated by an impartial witness who was present throughout the entire informed consent process confirming that the maternal participant has been informed of all pertinent aspects of the study.
- Evidence of a signed and dated ICD signed by the parent(s)/legal guardian(s) OR If the infant participant's maternal participant/parent(s)/legal guardian(s) is illiterate, a thumbprinted informed consent must have been obtained, which must have been signed and dated by an impartial witness who was present throughout the entire informed consent process confirming that the maternal participant/parent(s)/legal guardian(s) has been informed of all pertinent aspects of the study for herself (maternal participant) and her fetus/infant prior to taking part in the study.
- Parent(s)/legal guardian(s) willing and able to comply with scheduled visits, treatment plan, laboratory tests, and other study procedures.
You may not qualify if:
- Prepregnancy body mass index (BMI) of \>40 kg/m2. If prepregnancy BMI is not available, the BMI at the time of the first obstetric visit during the current pregnancy may be used.
- Bleeding diathesis or condition associated with prolonged bleeding that would, in the opinion of the investigator, contraindicate intramuscular injection.
- History of severe adverse reaction associated with a vaccine and/or severe allergic reaction (eg, anaphylaxis) to any component of the investigational product or any related vaccine.
- Current pregnancy resulting from in vitro fertilization.
- Current pregnancy complications or abnormalities at the time of consent that will increase the risk associated with the participation in and completion of the study, including but not limited to the following:
- Preeclampsia, eclampsia, or uncontrolled gestational hypertension.
- Placental abnormality.
- Polyhydramnios or oligohydramnios.
- Significant bleeding or blood clotting disorder.
- Endocrine disorders, including untreated hyperthyroidism or untreated hypothyroidism. This also includes disorders of glucose intolerance (eg, diabetes mellitus type 1 or 2) antedating pregnancy or occurring during pregnancy if uncontrolled at the time of consent.
- Any signs of premature labor with the current pregnancy or having ongoing intervention (medical/surgical) in the current pregnancy to prevent preterm birth.
- Prior pregnancy complications or abnormalities at the time of consent, based on the investigator's judgment, that will increase the risk associated with the participation in and completion of the study, including but not limited to the following:
- Prior preterm delivery ≤34 weeks' gestation.
- Prior stillbirth or neonatal death.
- Previous infant with a known genetic disorder or significant congenital anomaly.
- +10 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Pfizerlead
Study Sites (464)
Central Research Associates, Inc.
Birmingham, Alabama, 35205, United States
Endocrinology and Internal Medicine Associates, PC
Birmingham, Alabama, 35205, United States
OB/GYN Associates of Alabama, PC
Birmingham, Alabama, 35205, United States
Sharp and Stone OB/GYN PC
Birmingham, Alabama, 35205, United States
St Vincent's Hospital
Birmingham, Alabama, 35205, United States
Children's of Alabama
Birmingham, Alabama, 35233, United States
UAB Women & Infants Center - UAB Medicine
Birmingham, Alabama, 35233, United States
University of Alabama at Birmingham/Center for Women's Reproductive Health
Birmingham, Alabama, 35233, United States
Cullman Clinical Research, Inc
Cullman, Alabama, 35058, United States
Cullman Primary Care, PC
Cullman, Alabama, 35058, United States
Cullman Regional
Cullman, Alabama, 35058, United States
University of South Alabama Children's and Women's Hospital
Mobile, Alabama, 36604, United States
USA Health Strada Patient Care Center
Mobile, Alabama, 36604, United States
Springhill Medical Center
Mobile, Alabama, 36608, United States
Velocity Clinical Research, Gulfport
Mobile, Alabama, 36608, United States
Velocity Clinical Research - Pheonix
Phoenix, Arizona, 85006, United States
Valleywise Comprehensive Health Center Women's Clinic
Phoenix, Arizona, 85008, United States
Valleywise Health Medical Center
Phoenix, Arizona, 85008, United States
Mesquite Pediatrics
Tucson, Arizona, 85712, United States
Watching Over Mothers and Babies
Tucson, Arizona, 85712, United States
Banner University Medical Center
Tucson, Arizona, 85724, United States
University of Arizona
Tucson, Arizona, 85724, United States
Banner University Medical Center ( North Campus )
Tucson, Arizona, 87519, United States
St. Bernards Medical Center
Jonesboro, Arkansas, 72401, United States
St. Bernards OBGYN Associates
Jonesboro, Arkansas, 72401, United States
The Children's Clinic of Jonesboro, P.A.
Jonesboro, Arkansas, 72401, United States
The Children's Clinic of Jonesboro, PA
Jonesboro, Arkansas, 72401, United States
Century Research Institute
Bellflower, California, 90706, United States
Chowchilla Medical Center
Chowchilla, California, 93610, United States
Loma Linda University Pediatric Clinic - Highland
Highland, California, 92346, United States
Century Research Institute
Huntington Park, California, 90255, United States
Matrix Clinical Research
Huntington Park, California, 90255, United States
Chemidox Clinical Trials
Lancaster, California, 93534, United States
Leonard S. Kurian, M.D., A Medical Corporation
Lancaster, California, 93534, United States
Women & Infants Pavilion, Antelope Valley Hospital
Lancaster, California, 93534, United States
Loma Linda University Adventist Health Sciences Center
Loma Linda, California, 92354, United States
Loma Linda University Faculty Medical Clinics
Loma Linda, California, 92354, United States
Loma Linda University Pediatric Clinics
Loma Linda, California, 92354, United States
Loma Linda Unversity Children's Hospital
Loma Linda, California, 92354, United States
Long Beach Clinical Trials
Long Beach, California, 90806, United States
Long Beach Memorial Medical Center
Long Beach, California, 90806, United States
St Mary Medical Center
Long Beach, California, 90806, United States
Century Research Institute
Los Angeles, California, 90006, United States
Matrix Clinical Research..
Los Angeles, California, 90006, United States
East LA Doctors Hospital
Los Angeles, California, 90023, United States
Hollywood Presbyterian Medical Center
Los Angeles, California, 90027, United States
Century Research Institute
Los Angeles, California, 90033, United States
White Memorial Medical Center
Los Angeles, California, 90033, United States
Peter Morton Medical Building
Los Angeles, California, 90095, United States
Ronald Reagan UCLA Medical Center Drug Information Center Dept
Los Angeles, California, 90095, United States
Ronald Reagan University of California Los Angeles Medical Center
Los Angeles, California, 90095, United States
UCLA David Geffen School of Medicine
Los Angeles, California, 90095, United States
Affiliated Physician Practice
Madera, California, 93637, United States
Charles E. Ugwu-Oju, M.D., F.A.C.O.G., Obstetrics & Gynecology
Madera, California, 93637, United States
Madera Community Hospital
Madera, California, 93637, United States
Madera Family Medical Group
Madera, California, 93637, United States
Monterey Park Hospital
Monterey Park, California, 91754, United States
Lucile Packard Children's Hospital
Palo Alto, California, 94304, United States
Stanford University
Palo Alto, California, 94304, United States
Fomat- Raymond Poliakin, MD.
Thousand Oaks, California, 91360, United States
Carey Chronis, MD
Ventura, California, 93003, United States
Children's Hospital Colorado
Aurora, Colorado, 80045, United States
University of Colorado Anschutz Inpatient Pavilion 2
Aurora, Colorado, 80045, United States
University of Colorado AO1
Aurora, Colorado, 80045, United States
University of Colorado Hospital Inpatient Pavilion
Aurora, Colorado, 80045, United States
University of Colorado Hospital Outpatient Pavilion
Aurora, Colorado, 80045, United States
University of Colorado Hospital
Aurora, Colorado, 80045, United States
University of Colorado Leprino Building
Aurora, Colorado, 80045, United States
University of Colorado Research II Building
Aurora, Colorado, 80045, United States
Delta Memorial Hospital
Delta, Colorado, 81416, United States
Colorado Canyon's Hospital
Fruita, Colorado, 81521, United States
Boeson Research
Grand Junction, Colorado, 81501, United States
Dino-Peds
Grand Junction, Colorado, 81501, United States
Women's Health Care of Western Colorado
Grand Junction, Colorado, 81501, United States
Boeson Research
Grand Junction, Colorado, 81505, United States
Community Hospital
Grand Junction, Colorado, 81505, United States
SCL St. Mary's Medical Center
Grand Junction, Colorado, 81505, United States
Montrose Memorial Hospital
Montrose, Colorado, 81401, United States
Yale School Medicine Church Street Research Unit
New Haven, Connecticut, 06519, United States
Emerson Clinical Research Institute
Washington D.C., District of Columbia, 20011, United States
Axcess Medical Research
Loxahatchee Groves, Florida, 33470, United States
North Shore Medical Center
Miami, Florida, 33150, United States
Citadelle Clinical Research
North Miami Beach, Florida, 33162, United States
A1 Imaging of Aventura
North Miami Beach, Florida, 33180, United States
Baldwin Pediatrics
Panama City, Florida, 32405, United States
Emerald Coast Obstetrics and Gynecology
Panama City, Florida, 32405, United States
Emerald Coast Pediatrics
Panama City, Florida, 32405, United States
Gulf Coast Regional Medical Center
Panama City, Florida, 32405, United States
Rainbow Pediatrics
Panama City, Florida, 32405, United States
Rainbow Pediatrics
Panama City Beach, Florida, 32407, United States
American Research Centers of Florida
Pembroke Pines, Florida, 33027, United States
Emory University Hospital Midtown
Atlanta, Georgia, 30308, United States
Emory Clinic
Atlanta, Georgia, 30322, United States
Emory University Investigational Drug Service
Atlanta, Georgia, 30322, United States
Emory University School of Medicine
Atlanta, Georgia, 30322, United States
Piedmont Columbus Regional Midtown
Columbus, Georgia, 31901, United States
Columbus Regional Research Institute
Columbus, Georgia, 31904, United States
1st Choice Urgent Care & Family Medicine
Blackfoot, Idaho, 83221, United States
Bingham Memorial Hospital
Blackfoot, Idaho, 83221, United States
Elite Clinical Trials LLLP
Blackfoot, Idaho, 83221, United States
Grove Creek Medical Center
Blackfoot, Idaho, 83221, United States
ASR, LLC
Boise, Idaho, 83702, United States
Saint Alphonsus Regional Medical Center
Boise, Idaho, 83706, United States
St. Luke's Boise Medical Center
Boise, Idaho, 83712, United States
West Valley Medical Center
Caldwell, Idaho, 83605, United States
Clinical Research Prime
Idaho Falls, Idaho, 83404, United States
Eastern Idaho Regional Medical Center
Idaho Falls, Idaho, 83404, United States
Mountain View Hospital
Idaho Falls, Idaho, 83404, United States
The Pediatric Center
Idaho Falls, Idaho, 83404, United States
Saltzer Health
Meridian, Idaho, 83642, United States
St. Luke's Meridian Medical Center
Meridian, Idaho, 83642, United States
Saltzer Health
Nampa, Idaho, 83686, United States
ASR, LLC
Nampa, Idaho, 83687, United States
Saltzer Health
Nampa, Idaho, 83687, United States
St. Alphonsus Medical Center- Nampa
Nampa, Idaho, 83687, United States
St. Luke's Nampa Medical Center
Nampa, Idaho, 83687, United States
Pocatello Women's Health Clinic
Pocatello, Idaho, 83201, United States
Portneuf Medical Center
Pocatello, Idaho, 83201, United States
1st Choice Urgent Care
Pocatello, Idaho, 83204, United States
Clinical Research Prime Rexburg
Rexburg, Idaho, 83440, United States
Elite Clinical Trials LLLP
Rexburg, Idaho, 83440, United States
Madison Memorial Hospital
Rexburg, Idaho, 83440, United States
The Pediatric Center
Rigby, Idaho, 83442, United States
Dupont Pediatrics
Fort Wayne, Indiana, 46825, United States
Women's Health Advantage
Fort Wayne, Indiana, 46825, United States
Mary Greeley Medical Center
Ames, Iowa, 50010, United States
Mcfarland Clinic PC
Ames, Iowa, 50010, United States
McFarland Clinic, P.C.
Ames, Iowa, 50010, United States
The Iowa Clinic
Ankeny, Iowa, 50023, United States
Methodist West Hospital
West Des Moines, Iowa, 50266, United States
The Iowa Clinic, P.C.
West Des Moines, Iowa, 50266, United States
Alliance for Multispecialty Research, LLC
El Dorado, Kansas, 67042, United States
University of Kansas Medical Center
Kansas City, Kansas, 66160, United States
Alliance for Multispecialty Research, LLC
Newton, Kansas, 67114, United States
Owensboro Health Regional Hospital
Owensboro, Kentucky, 42303, United States
Research Integrity, LLC
Owensboro, Kentucky, 42303, United States
The Women's Pavillion, P.S.C
Owensboro, Kentucky, 42303, United States
Alexandria Cardiology Clinic - Secondary Research Site
Alexandria, Louisiana, 71301, United States
Cambridge Medical Trials - Main Research Site
Alexandria, Louisiana, 71301, United States
Cambridge Medical Trials
Alexandria, Louisiana, 71301, United States
Rabie Clinic for Women
Alexandria, Louisiana, 71301, United States
Rapides Regional Medical Center Labor and Delivery
Alexandria, Louisiana, 71301, United States
Lakeview Regional Medical Center
Covington, Louisiana, 70433, United States
St. Tammany Parish Hospital
Covington, Louisiana, 70433, United States
Velocity Clinical Research
Covington, Louisiana, 70433, United States
Ochsner Health Center - West Bank
Gretna, Louisiana, 70056, United States
North Oaks Medical Center
Hammond, Louisiana, 70131, United States
North Oaks Obstetrics & Gynecology
Hammond, Louisiana, 70403, United States
North Oaks Rural Health Clinic
Hammond, Louisiana, 70403, United States
MedPharmics LLC
Lafayette, Louisiana, 70508, United States
Crescent City Physicians and Obstetrics
Metairie, Louisiana, 70005, United States
MedPharmics LLC
Metairie, Louisiana, 70006, United States
Ochsner Baptist Medical Center
New Orleans, Louisiana, 70115, United States
Touro Infirmary
New Orleans, Louisiana, 70115, United States
Ochsner Clinic Foundation
New Orleans, Louisiana, 70121, United States
Ochsner Health Center for Children
New Orleans, Louisiana, 70121, United States
Women Under Study, LLC
New Orleans, Louisiana, 70125, United States
Slidell Memorial Hospital
Slidell, Louisiana, 70458, United States
Velocity Clinical Research
Slidell, Louisiana, 70458, United States
Boston Medical Center
Boston, Massachusetts, 02118, United States
Investigational Pharmacy Service
Boston, Massachusetts, 02118, United States
C.S. Mott Center
Detroit, Michigan, 48201, United States
Hutzel-Harper Women's Hospital
Detroit, Michigan, 48201, United States
University Health Center
Detroit, Michigan, 48201, United States
Wayne State University Physician Group
Southfield, Michigan, 48034, United States
Velocity Clinical Research
Gulfport, Mississippi, 39503, United States
Barnes Jewish Hospital
St Louis, Missouri, 63110, United States
St. Louis Children's Hospital
St Louis, Missouri, 63110, United States
Washington University School of Medicine
St Louis, Missouri, 63110, United States
Baer Pediatrics
St Louis, Missouri, 63131, United States
KDB Enterprises
St Louis, Missouri, 63141, United States
Sundance Clinical Research, LLC
St Louis, Missouri, 63141, United States
Boeson Research (BUT)
Butte, Montana, 59701, United States
St James Healthcare
Butte, Montana, 59701, United States
Benefis Health System
Great Falls, Montana, 59405, United States
Origin Health GTF
Great Falls, Montana, 59405, United States
Boeson Research (GTF)
Great Falls, Montana, 59804, United States
Marcus Daly Memorial Hospital
Hamilton, Montana, 59840, United States
Boeson Research (HLN)
Helena, Montana, 59601, United States
St Peters Health
Helena, Montana, 59601, United States
Boeson Reseach (KAL)
Kalispell, Montana, 59901, United States
Kalispell Regional Medical Center
Kalispell, Montana, 59901, United States
The Birth Center
Missoula, Montana, 59803, United States
Boeson Research LLC
Missoula, Montana, 59804, United States
Boeson Research
Missoula, Montana, 59804, United States
Community Medical Center
Missoula, Montana, 59804, United States
Community Physicians Group-Maternal Fetal Medicine
Missoula, Montana, 59804, United States
St Luke Community Clinic - Ronan
Ronan, Montana, 59864, United States
North Valley Hospital
Whitefish, Montana, 59937, United States
Grand Island Regional Medical Center
Grand Island, Nebraska, 68801, United States
CHI Health St. Francis
Grand Island, Nebraska, 68803, United States
Meridian Clinical Research, LLC
Grand Island, Nebraska, 68803, United States
Mary Lanning
Hastings, Nebraska, 68901, United States
Meridian Clinical Research
Hastings, Nebraska, 68901, United States
Midwest Children's Health Research Institute
Lincoln, Nebraska, 68504, United States
Midwest Children's Health Research Institute.
Lincoln, Nebraska, 68505, United States
Bryan Health
Lincoln, Nebraska, 68506, United States
Midwest Childrens Health Research Institute
Lincoln, Nebraska, 68516, United States
Women's Health Care Center of Williamsburg
Lincoln, Nebraska, 68516, United States
Midwest Children's Health Research Institute
Lincoln, Nebraska, 68522, United States
Velocity Clinical Research, Norfolk
Norfolk, Nebraska, 68701, United States
Cooper University Hospital
Camden, New Jersey, 08103, United States
Jaffe Family Womens Care Center
Camden, New Jersey, 08103, United States
Pediatrics at Sheridan Pavilion- Three Cooper Plaza
Camden, New Jersey, 08103, United States
Cooper Faculty OBGYN at Cherry Hill
Cherry Hill, New Jersey, 08034, United States
Saint Peters University Hospital
New Brunswick, New Jersey, 08901, United States
Cooper Faculty OBGYN at Sewell
Sewell, New Jersey, 08080, United States
MedPharmics
Albuquerque, New Mexico, 87102, United States
Presbyterian Hospital
Albuquerque, New Mexico, 87106, United States
University of New Mexico Hospital
Albuquerque, New Mexico, 87106, United States
Velocity Clinical Research, Albuquerque
Albuquerque, New Mexico, 87107, United States
Lovelace Women's Hospital
Albuquerque, New Mexico, 87109, United States
New York Presbyterian of Queens Hospital
Flushing, New York, 11355, United States
Theresa Lang Children's Ambulatory Center
Flushing, New York, 11355, United States
Fresh Meadows Family Health Center
Fresh Meadows, New York, 11365, United States
Hollis Women's Center
Hollis, New York, 11423, United States
Jackson Heights Family Health Center
Jackson Heights, New York, 11372, United States
NYU Langone Hospital - Long Island
Mineola, New York, 11501, United States
Women's Contemporary Care
Mineola, New York, 11501, United States
Columbia Doctors
New York, New York, 10019, United States
Audubon Clinic
New York, New York, 10032, United States
Center for Prenatal Pediatrics
New York, New York, 10032, United States
Columbia University Irving Medical Center
New York, New York, 10032, United States
Herbert Irving Pavilion
New York, New York, 10032, United States
Morgan Stanley Childrens Hospital
New York, New York, 10032, United States
Meridian Clinical Research LLC
Vestal, New York, 13850, United States
UNC OB/GYN at Panther Creek (recruitment, randomization, administration of IP)
Cary, North Carolina, 27519, United States
UNC Children's Hospital (Pediatric follow up)
Chapel Hill, North Carolina, 27514, United States
UNC Healthcare (recruitment, randomization, administration of IP)
Chapel Hill, North Carolina, 27514, United States
UNC OB/GYN at Weaver Crossing (recruitment, randomization, administration of IP)
Chapel Hill, North Carolina, 27514, United States
Duke Children's Primary Care - Roxboro Street
Durham, North Carolina, 27704, United States
Duke Regional Hospital
Durham, North Carolina, 27704, United States
Duke University.
Durham, North Carolina, 27705, United States
Duke University Hospital
Durham, North Carolina, 27710, United States
Womack Army Medical Center
Fort Bragg, North Carolina, 28310, United States
FirstHealth Clinical Trials
Pinehurst, North Carolina, 28374, United States
FirstHealth Moore Regional Hospital
Pinehurst, North Carolina, 28374, United States
Sandhills Pediatrics
Seven Lakes, North Carolina, 27376, United States
Sandhills Pediatrics
Southern Pines, North Carolina, 28387, United States
FirstHealth Southern Pines Women's Health Center
Southern Pines, North Carolina, 28388, United States
The Christ Hospital
Cincinnati, Ohio, 45219, United States
University of Cincinnati Medical Center Department of Obstetrics and Gynecology
Cincinnati, Ohio, 45219, United States
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, 45229, United States
Dayton Clinical Research
Dayton, Ohio, 45409, United States
HWC Women's Research Center, LLC
Englewood, Ohio, 45322, United States
UC Health West Chester Hospital
West Chester, Ohio, 45069, United States
Integris Yukon Hospital
Yukon, Oklahoma, 73099, United States
Tekton Research
Yukon, Oklahoma, 73099, United States
Allegheny Health and Wellness Pavilion
Erie, Pennsylvania, 16506, United States
OBGYN Associates of Erie
Erie, Pennsylvania, 16507, United States
Liberty Family Practice
Erie, Pennsylvania, 16508, United States
Saint Vincent Hospital
Erie, Pennsylvania, 16544, United States
Reading Hospital - Children's Health Center
West Reading, Pennsylvania, 19611, United States
Reading Hospital - Women's Health Center
West Reading, Pennsylvania, 19611, United States
Reading Hospital-Family Health Care Center
West Reading, Pennsylvania, 19611, United States
Reading Hospital
West Reading, Pennsylvania, 19611, United States
Bon Secours St. Francis Hospital
Charleston, South Carolina, 29414, United States
Charleston 0B/GYN
Charleston, South Carolina, 29414, United States
Coastal Pediatric Research
Charleston, South Carolina, 29414, United States
Prisma Health-Upstate Office of Maternal Fetal Medicine
Greenville, South Carolina, 29605, United States
Prisma Health
Greenville, South Carolina, 29605, United States
Lowcountry Womens Specialists
Summerville, South Carolina, 29485, United States
Summerville Medical Center
Summerville, South Carolina, 29485, United States
Coastal Pediatric Research
Summerville, South Carolina, 29486, United States
Sanford Obstetrics and Gynecology Clinic (Recruitment, Consenting, IP Administration, and Follow Up)
Sioux Falls, South Dakota, 57105, United States
Sanford Obstetrics and Gynecology Clinic
Sioux Falls, South Dakota, 57105, United States
Sanford USD Medical Center (Main Hospital)
Sioux Falls, South Dakota, 57105, United States
Sanford Women's Health Plaza (Recruitment, Consenting, and Follow Up)
Sioux Falls, South Dakota, 57108, United States
Premier Medical Group
Clarksville, Tennessee, 37040, United States
University of Tennessee Medical Center
Knoxville, Tennessee, 37920, United States
Texas Health Arlington Memorial Hospital
Arlington, Texas, 76012, United States
Ventavia Research Group, LLC
Arlington, Texas, 76012, United States
Medical City Arlington (Women's Hospital)
Arlington, Texas, 76015, United States
St. David's Medical Center
Austin, Texas, 78705, United States
Tekton Research, Inc.
Austin, Texas, 78705, United States
Center for Women''s Health and Birthcare
Beaumont, Texas, 77702, United States
Christus St. Elizabeth Hospital
Beaumont, Texas, 77702, United States
Gadolin Research, LLC
Beaumont, Texas, 77702, United States
Texas Health Harris Methodist Hospital Hurst-Euless-Bedford
Bedford, Texas, 76022, United States
Child Care Pediatrics, P.A.
Burleson, Texas, 76028, United States
Ventavia Research Group LLC
Burleson, Texas, 76028, United States
Texas Health Presbyterian Hospital Dallas
Dallas, Texas, 75231, United States
Ventavia Research Group LLC
Dallas, Texas, 75231, United States
Wise Health System Dectaur
Decatur, Texas, 76243, United States
Cline Pediatrics
Dickinson, Texas, 77539, United States
Doctor's Hospital Womens Hospital
Edinburg, Texas, 78539, United States
South Texas Health System- Edinburg
Edinburg, Texas, 78539, United States
8th Avenue Obstetrics & Gynecology
Fort Worth, Texas, 76104, United States
Baylor Scott & White All Saints Medical Center
Fort Worth, Texas, 76104, United States
Texas Health Harris Methodist Hospital Fort Worth
Fort Worth, Texas, 76104, United States
Ventavia Research Group, LLC
Fort Worth, Texas, 76104, United States
Texas Health Harris Methodist Hospital Southwest
Fort Worth, Texas, 76132, United States
University of Texas Medical Branch
Galveston, Texas, 77555, United States
Chisholm Trail Pediatrics
Georgetown, Texas, 78626, United States
FMC Science
Georgetown, Texas, 78626, United States
St. David's Georgetown Hospital
Georgetown, Texas, 78626, United States
Baylor Scott & White of Grapevine (Hospital)
Grapevine, Texas, 76051, United States
Ventavia Research Group, LLC
Grapevine, Texas, 76051, United States
Hany H. Ahmed, MD
Houston, Texas, 77008, United States
HG Pediatrics
Houston, Texas, 77008, United States
Van Tran Family Clinic
Houston, Texas, 77008, United States
Ventavia Research Group, LLC
Houston, Texas, 77008, United States
Memorial Hermann Memorial City
Houston, Texas, 77024, United States
UT Health Women's Research Center at Memorial City
Houston, Texas, 77024, United States
HCA: The Women's Hospital of Texas
Houston, Texas, 77054, United States
Javara Inc.
Houston, Texas, 77054, United States
Privia Medical Group Gulf Coast, PLLC
Houston, Texas, 77054, United States
Texas Center for Drug Development, Inc
Houston, Texas, 77081, United States
AdventHealth Family Medicine Rural Health Clinic, Inc.
Lampasas, Texas, 76550, United States
FMC Science
Lampasas, Texas, 76550, United States
Maximos Ob/Gyn
League City, Texas, 77573, United States
DCOL Center for Clinical Research
Longview, Texas, 75605, United States
Diagnostic Clinic of Longview (Hollybrook)
Longview, Texas, 75605, United States
Diagnostic Clinic of Longview (Medical Circle)
Longview, Texas, 75605, United States
Longview Regional Medical Center
Longview, Texas, 75605, United States
Rio Grande Regional Hospital
McAllen, Texas, 78503, United States
South Texas Health System- McAllen
McAllen, Texas, 78503, United States
Dr. Ruben Aleman and Associates
McAllen, Texas, 78504, United States
Medical City Plano
Plano, Texas, 75075, United States
Texas Health Presbyterian Hospital Plano
Plano, Texas, 75093, United States
Ventavia Research Group LLC
Plano, Texas, 75093, United States
St. Luke's Baptist Hospital
San Antonio, Texas, 78229, United States
Tekton Research, LLC.
San Antonio, Texas, 78229, United States
DM Clinical Research
Tomball, Texas, 77375, United States
Medical City Weatherford
Weatherford, Texas, 76086, United States
Ventavia Research Group
Weatherford, Texas, 76086, United States
Alpine Medical Group
Salt Lake City, Utah, 84102, United States
Intermountain Medical Center
Salt Lake City, Utah, 84107, United States
JBR Clinical Research
Salt Lake City, Utah, 84107, United States
Old Farm Obstetrics & Gynecology, LLC
Salt Lake City, Utah, 84107, United States
Holladay Family Practice
Salt Lake City, Utah, 84117, United States
St. Marks Hospital
Salt Lake City, Utah, 84124, United States
University of Utah Hospital
Salt Lake City, Utah, 84132, United States
University of Utah
Salt Lake City, Utah, 84132, United States
Sentara Leigh Hospital
Norfolk, Virginia, 23502, United States
The Group for Women
Norfolk, Virginia, 23502, United States
Tidewater Physicians for Women
Norfolk, Virginia, 23502, United States
Clinical Research Partners, LLC
North Chesterfield, Virginia, 23235, United States
Virginia Commonwealth Univeristy Health Systems-Children's Pavilion
Richmond, Virginia, 23219, United States
Virginia Commonwealth University Health System-Main Hospital
Richmond, Virginia, 23219, United States
Virginia Commonwealth University Health System-Nelson Clinic
Richmond, Virginia, 23219, United States
Clinical Research Partners, LLC
Richmond, Virginia, 23226, United States
VCU Health Adult Outpatient Pavillion
Richmond, Virginia, 23298, United States
Virginia Commonwealth University
Richmond, Virginia, 23298, United States
Tidewater Physicians for Women
Virginia Beach, Virginia, 23462, United States
Seattle Children's Hospital
Seattle, Washington, 98105, United States
UW Neighborhood Ravenna Clinic
Seattle, Washington, 98105, United States
UW Neighborhood South Lake Union Clinic
Seattle, Washington, 98109, United States
University of Washington Medical Center - Northwest
Seattle, Washington, 98133, United States
UW Midwives Clinic at Northwest Outpatient Medical center
Seattle, Washington, 98133, United States
University of Washington Medical Center- Montlake
Seattle, Washington, 98195, United States
UW Neighborhood Shoreline Clinic
Shoreline, Washington, 98133, United States
MultiCare Health System - Mary Bridge Children's Health Center
Tacoma, Washington, 98405, United States
Multicare Health System-Multicare Women's Center Tacoma
Tacoma, Washington, 98405, United States
Multicare Health System-Pediatrics Northwest
Tacoma, Washington, 98405, United States
Multicare Health System-Tacoma General Hospital
Tacoma, Washington, 98405, United States
MultiCare Institute for Research & Innovation
Tacoma, Washington, 98405, United States
Cabell Huntington Hospital
Huntington, West Virginia, 25701, United States
Marshall Health
Huntington, West Virginia, 25701, United States
University Physicians and Surgeons dba Marshall Health Department of Obstetrics and Gynecology
Huntington, West Virginia, 25701, United States
University Physicians and Surgeons dba Marshall Health Department of Pediatrics
Huntington, West Virginia, 25701, United States
Marshfield Medical Center - Marshfield
Marshfield, Wisconsin, 54449, United States
Marshfield Medical Center
Marshfield, Wisconsin, 54449, United States
Clínica del Niño y la Madre
Mar del Plata, Buenos Aires, 7600, Argentina
Hospital Italiano de Rosario
Rosario, Santa Fe Province, 2000, Argentina
Clinica Mayo de Urgencias Medicas Cruz Blanca S.R.L
San Miguel de Tucumán, Tucumán Province, 4000, Argentina
Instituto de Maternidad y Ginecologia: "Nuestra Senora de las Mercedes"
San Miguel de Tucumán, Tucumán Province, 4000, Argentina
Sanatorio Mater Dei
Buenos Aires, 1425, Argentina
Centro de Investigación Clinica OSECAC
Buenos Aires, C1040 AAL, Argentina
Hospital Militar Central Cirujano Mayor Dr. Cosme Argerich
CABA, C1426BOS, Argentina
Hospital Publico Materno Infantil
Salta, 4400, Argentina
Women's and Children's Hospital
North Adelaide, South Australia, 5006, Australia
Monash Children's Hospital
Clayton, Victoria, 3168, Australia
Barwon Health, University Hospital Geelong
Geelong, Victoria, 3220, Australia
Telethon Kids Institute
Nedlands, Western Australia, 6009, Australia
St John of God Hospital Subiaco
Subiaco, Western Australia, 6008, Australia
Hospital Universitario/GAMP - Grupo de Apoio a Medicina Preventiva e a Saude Publica
Canoas, Rio Grande do Sul, 92425-900, Brazil
Hospital Moinhos de Vento - HMV
Porto Alegre, Rio Grande do Sul, 90035-001, Brazil
Hospital Moinhos de Vento - HMV
Porto Alegre, Rio Grande do Sul, 90560-030, Brazil
Maternidade Darcy Vargas
Joinville, Santa Catarina, 89202-190, Brazil
Clinica de Alergia Martti Antila S/S Ltda./ CMPC - Consultoria Medica e Pesquisa Clinica
Sorocaba, São Paulo, 18040-425, Brazil
Canadian Center for Vaccinology - IWK Health Centre
Halifax, Nova Scotia, B3K 6R8, Canada
CHU Sainte-Justine
Montreal, Quebec, H3T 1C5, Canada
CHU de Québec-Université Laval
Québec, Quebec, G1V 4G2, Canada
Hospital Base San José de Osorno (Servicio de Obstetricia y Ginecología)
Osorno, Los Lagos Region, 5311523, Chile
Centro de Capacitación e Investigaciones Clínicas (CCIC)
Santiago, Santiago Metropolitan, 7510186, Chile
Clinica Universidad de los Andes
Santiago, Santiago Metropolitan, 7620157, Chile
Satellite (Deliveries): Hospital San Juan de Dios (Maternidad)
Santiago, Santiago Metropolitan, 8350488, Chile
Instituto de Investigaciones Materno Infantil (IDIMI)
Santiago, Santiago Metropolitan, 8360160, Chile
Deliveries (satellite): Hospital San Jose
Santiago, Santiago Metropolitan, 8380419, Chile
Grupo Estudios Clínicos Infectología Respiratoria
Santiago, Santiago Metropolitan, 8380453, Chile
Deliveries (satellite): Hospital Clínico Universidad de Chile
Santiago, Santiago Metropolitan, 8380456, Chile
Centro Internacional de Estudios Clinicos - CIEC
Santiago, Santiago Metropolitan, 8420383, Chile
Hospital Padre Hurtado
Santiago, Santiago Metropolitan, 8880465, Chile
Aarhus Universitetshospital
Aarhus N, 8200, Denmark
Nordsjællands Hospital
Hillerød, 3400, Denmark
Hvidovre Hospital
Hvidovre, 2650, Denmark
Odense Universitets Hospital
Odense, DK-5000, Denmark
MeVac
Helsinki, 00290, Finland
Kokkola Vaccine Research Clinic
Kokkola, 67100, Finland
Oulu Vaccine Research Clinic
Oulu, 90220, Finland
Tampereen yliopisto Oulun Rokotetutkimusklinikka
Oulu, 90220, Finland
Pori Vaccine Research Clinic
Pori, 28100, Finland
Seinajoki Vaccine Research Clinic
Seinäjoki, 60100, Finland
Tampere Vaccine Research Clinic
Tampere, 33100, Finland
Turku Vaccine Research Clinic
Turku, 20520, Finland
Fukui Aiiku Hospital
Fukui-shi, Fukui, 910-0833, Japan
Hyogo Prefectural Amagasaki General Medical Center
Amagasaki, Hyōgo, 660-8550, Japan
Shonan Fujisawa Tokushukai Hospital
Fujisawa, Kanagawa, 251-0041, Japan
Rakuwakai Otowa Hospital
Kyoto, Kyoto, 607-8062, Japan
Kuwana City Medical Center
Kuwana-shi, Mie-ken, 511-0061, Japan
Sendai City Hospital
Sendai, Miyagi, 982-8502, Japan
National Hospital Organization Beppu Medical Center
Beppu, Oita Prefecture, 874-0011, Japan
Social Medical Corporation KARIYUSHIKAI Heartlife Hospital
Nakagami-gun, Okinawa, 901-2492, Japan
Osaka Habikino Medical Center
Habikino, Osaka, 583-8588, Japan
National Hospital Organization Tokyo Medical Center
Meguro-ku, Tokyo, 152-8902, Japan
Saitama City hospital
Saitama, 336-8522, Japan
Shizuoka General Hospital
Shizuoka, 420-8527, Japan
Asociacion Mexicana para la Investigacion Clinica, A. C.
Pachuca, Hidalgo, 42070, Mexico
Arke SMO S.A. de C.V.
Cuauhtémoc, Mexico City, 06700, Mexico
Hospital Universitario "Dr. Jose Eleuterio Gonzalez"
Monterrey, Nuevo León, 64460, Mexico
Hospital General de Durango
Durango, 34000, Mexico
Arke SMO S.A. de C.V.
Veracruz, 91910, Mexico
Spaarne Gasthuis (Kennemer Gasthuis)
Hoofddorp, 2134 TM, Netherlands
Diakonessenhuis Utrecht
Utrecht, 3582 KE, Netherlands
University Medical Center Utrecht
Utrecht, 3584 CX, Netherlands
Botany Downs Primary Birthing Unit
Golflands, Auckland, 2013, New Zealand
Papakura Primary Birthing Unit
Papakura North, Auckland, 2110, New Zealand
Middlemore Hospital
Papatoetoe, Auckland, 2025, New Zealand
Pukekohe Primary Birthing Unit
Pukekohe, Auckland, 2120, New Zealand
New Zealand Clinical Research (Christchurch)
Christchurch, Canterbury, 8011, New Zealand
Optimal Clinical Trials Ltd
Auckland, 1010, New Zealand
Aotearoa Clinical Trials Trust (ACTT)
Auckland, 2025, New Zealand
Christchurch Hospital (Canterbury District Health Board)
Christchurch, 8011, New Zealand
Capital, Coast and Hutt Valley District- Wellington Regional Hospital
Wellington, 6021, New Zealand
Asian Hospital and Medical Center
Muntinlupa City, National Capital Region, 1780, Philippines
JOSHA Research
Bloemfontein, Free State, 9300, South Africa
Wits RHI Shandukani Research Centre
Johannesburg, Gauteng, 2001, South Africa
Into Research, West Wing Medical Centre
Pretoria, Gauteng, 0181, South Africa
Setshaba Research Centre
Soshanguve, Gauteng, 0152, South Africa
University of the Witwatersrand Vaccines & Infectious Diseases Analytics (VIDA)
Soweto, Gauteng, 1862, South Africa
Limpopo Clinical Research Initiative
Thabazimbi, Limpopo, 0380, South Africa
MRC Unit on Child and Adolescent Health
Cape Town, Western Cape, 7700, South Africa
Khayelitsha Satellite Site: Michael Mapongwana Community Health Centre
Khayelitsha, Western Cape, 7784, South Africa
FAMCRU, University of Stellenbosch, Paediatric
Parow Valley, Western Cape, 7505, South Africa
Kraaifontein Satellite site
Cape Town, 7570, South Africa
Worcester Satellite site
Worcester, 6850, South Africa
Chonnam National University Hospital
Gwangju, 61469, South Korea
Seoul National University Hospital
Seoul, 03080, South Korea
Kyunghee University Hospital at Gangdong
Seoul, 05278, South Korea
Korea University Guro Hospital
Seoul, 08308, South Korea
CHUS - Hospital Clinico Universitario
Santiago de Compostela, A Coruna, 15706, Spain
Hospital de Antequera
Antequera, Malaga, 29200, Spain
Hospital Universitario 12 de Octubre
Madrid, 28041, Spain
Hospital Universitario La Paz
Madrid, 28046, Spain
Hospital Madrid Puerta del Sur Mostoles
Móstoles, 28938, Spain
Hospital Universitari i Politecnic La Fe
Valencia, 46026, Spain
Hsinchu MacKay Memorial Hospital
Hsinchu, 30071, Taiwan
Kaohsiung Medical University Chung-Ho Memorial Hospital
Kaohsiung City, 807, Taiwan
National Taiwan University Hospital
Taipei, 100, Taiwan
Mackay Memorial Hospital
Taipei, 10449, Taiwan
Chang Gung Medical Foundation Linkou Chang Gung Memorial Hospital
Taoyuan District, 333, Taiwan
Medical Research Council Unit the Gambia at the London School of Hygiene & Tropical Medicine
Fajara KMC, The Gambia
Medical Research Council Unit the Gambia at the London School of Hygiene & Tropical Medicine (LSHTM)
Sukuta, The Gambia
Related Publications (8)
Bolanos R, Araos R, Gonzalez C, Sepulveda D, Falconi JF, Averin A, Atwood M, Quinn E, Law AW, Mendes D. Cost-effectiveness of strategies using preventive interventions to protect infants in Chile from respiratory syncytial virus. Expert Rev Vaccines. 2025 Dec;24(1):904-913. doi: 10.1080/14760584.2025.2562201. Epub 2025 Oct 2.
PMID: 40958705DERIVEDIlangovan K, Radley D, Patton M, Shittu E, Lino MM, Goulas C, Swanson KA, Anderson AS, Gurtman A, Munjal I. Integrated Analysis of the Safety Experience in Adults with the Bivalent Respiratory Syncytial Virus Prefusion F Vaccine. Vaccines (Basel). 2025 Aug 1;13(8):827. doi: 10.3390/vaccines13080827.
PMID: 40872913DERIVEDSimoes EAF, Pahud BA, Madhi SA, Kampmann B, Shittu E, Radley D, Llapur C, Baker J, Perez Marc G, Barnabas SL, Fausett M, Adam T, Perreras N, Van Houten MA, Kantele A, Huang LM, Bont LJ, Otsuki T, Vargas SL, Gullam J, Tapiero B, Stein RT, Polack FP, Zar HJ, Staerke NB, Padilla MD, Richmond PC, Sarwar UN, Baber J, Koury K, Lino MM, Kalinina EV, Li W, Cooper D, Anderson AS, Swanson KA, Gurtman A, Munjal I; MATISSE (Maternal Immunization Study for Safety and Efficacy) Clinical Trial Group. Efficacy, Safety, and Immunogenicity of the MATISSE (Maternal Immunization Study for Safety and Efficacy) Maternal Respiratory Syncytial Virus Prefusion F Protein Vaccine Trial. Obstet Gynecol. 2025 Feb 1;145(2):157-167. doi: 10.1097/AOG.0000000000005816. Epub 2025 Jan 2.
PMID: 39746212DERIVEDMadhi SA, Kampmann B, Simoes EAF, Zachariah P, Pahud BA, Radley D, Sarwar UN, Shittu E, Llapur C, Perez Marc G, Maldonado Y, Kachikis A, Zar HJ, Swanson KA, Lino MM, Anderson AS, Gurtman A, Munjal I. Preterm Birth Frequency and Associated Outcomes From the MATISSE (Maternal Immunization Study for Safety and Efficacy) Maternal Trial of the Bivalent Respiratory Syncytial Virus Prefusion F Protein Vaccine. Obstet Gynecol. 2025 Feb 1;145(2):147-156. doi: 10.1097/AOG.0000000000005817. Epub 2025 Jan 2.
PMID: 39746206DERIVEDNazareno AL, Wood JG, Muscatello DJ, Homaira N, Hogan AB, Newall AT. Estimating the cost-effectiveness of maternal respiratory syncytial virus (RSV) vaccination in Australia: A dynamic and economic modelling analysis. Vaccine. 2025 Feb 6;46:126651. doi: 10.1016/j.vaccine.2024.126651. Epub 2024 Dec 28.
PMID: 39733477DERIVEDOtsuki T, Akada S, Anami A, Kosaka K, Munjal I, Baber J, Shoji Y, Aizawa M, Swanson KA, Gurtman A. Efficacy and safety of bivalent RSVpreF maternal vaccination to prevent RSV illness in Japanese infants: Subset analysis from the pivotal randomized phase 3 MATISSE trial. Vaccine. 2024 Sep 17;42(22):126041. doi: 10.1016/j.vaccine.2024.06.009. Epub 2024 Jun 8.
PMID: 38853036DERIVEDKampmann B, Madhi SA, Munjal I, Simoes EAF, Pahud BA, Llapur C, Baker J, Perez Marc G, Radley D, Shittu E, Glanternik J, Snaggs H, Baber J, Zachariah P, Barnabas SL, Fausett M, Adam T, Perreras N, Van Houten MA, Kantele A, Huang LM, Bont LJ, Otsuki T, Vargas SL, Gullam J, Tapiero B, Stein RT, Polack FP, Zar HJ, Staerke NB, Duron Padilla M, Richmond PC, Koury K, Schneider K, Kalinina EV, Cooper D, Jansen KU, Anderson AS, Swanson KA, Gruber WC, Gurtman A; MATISSE Study Group. Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in Infants. N Engl J Med. 2023 Apr 20;388(16):1451-1464. doi: 10.1056/NEJMoa2216480. Epub 2023 Apr 5.
PMID: 37018474DERIVEDGinsburg AS, Srikantiah P. Respiratory syncytial virus: promising progress against a leading cause of pneumonia. Lancet Glob Health. 2021 Dec;9(12):e1644-e1645. doi: 10.1016/S2214-109X(21)00455-1. Epub 2021 Nov 11. No abstract available.
PMID: 34774184DERIVED
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- PfizerClinicalTrials.gov Call Center
- Organization
- Pfizer Inc.
Study Officials
- STUDY DIRECTOR
Pfizer CT.gov Call Center
Pfizer
Publication Agreements
- PI is Sponsor Employee
- No
- Restriction Type
- OTHER
- Restrictive Agreement
- Yes
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- This is a double-blinded, placebo-controlled study.
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 3, 2020
First Posted
June 9, 2020
Study Start
June 17, 2020
Primary Completion
October 27, 2023
Study Completion
October 27, 2023
Last Updated
February 11, 2025
Results First Posted
February 11, 2025
Record last verified: 2025-01
Data Sharing
- IPD Sharing
- Will share
Pfizer will provide access to individual de-identified participant data and related study documents (e.g. protocol, Statistical Analysis Plan (SAP), Clinical Study Report (CSR)) upon request from qualified researchers, and subject to certain criteria, conditions, and exceptions. Further details on Pfizer's data sharing criteria and process for requesting access can be found at: https://www.pfizer.com/science/clinical\_trials/trial\_data\_and\_results/data\_requests.